In acute and chronic severe experimental asthma models, we found that both genetic and pharmacological inhibition of SIRT6 attenuated the parameters of airway remodeling, including EMT, myofibroblast transition, and ECM, suggesting that SIRT6 is involved in the pathogensis of severe asthma. This evidence concerns the gene SIRT6 and asthma.